Evidence map›Paper›PMID 41993768›Full record

ArticleCureus2026

Delayed-Onset Autoimmune Hemolytic Anemia in Advanced HIV With Cerebral Toxoplasmosis.

Mohammed F Alahmadi, Oweida Aldosary, Amer Bugnah, Hamad Alyami

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohammed F AlahmadiDepartment of Internal Medicine, King Saud Medical City, Riyadh, SAU.
Oweida AldosaryDepartment of Infectious Diseases, King Saud Medical City, Riyadh, SAU.
Amer BugnahDepartment of Hematology and Oncology, King Saud Medical City, Riyadh, SAU.
Hamad AlyamiDepartment of Infectious Diseases, King Saud Medical City, Riyadh, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune hemolytic anemia (AIHA) is an uncommon immune-mediated complication of human immunodeficiency virus (HIV) infection and represents a rare cause of anemia in this population. While anemia in HIV is typically multifactorial, AIHA has most often been reported early in the disease course or around the initiation of antiretroviral therapy. Delayed-onset AIHA developing during prolonged hospitalization is rarely described, particularly in patients with advanced immunosuppression. We report a case of delayed-onset warm AIHA occurring more than two months after admission in a patient with newly diagnosed advanced HIV infection complicated by cerebral toxoplasmosis. The patient developed acute hemolysis with laboratory evidence of immune-mediated destruction of erythrocytes after a period of clinical stability. Secondary causes of hemolysis were excluded, and the patient demonstrated a favorable response to corticosteroid therapy without relapse. This case highlights that AIHA may occur late during hospitalization, including during periods of partial immune recovery following antiretroviral therapy. Clinicians should maintain a high index of suspicion for immune-mediated hemolysis in patients with HIV who develop unexplained anemia. Further studies are needed to better understand the mechanisms underlying delayed-onset AIHA and its relationship to immune reconstitution.

Indexed as

advanced hiv diseaseautoimmune hemolysisautoimmune hemolytic anemia (aiha)cerebral toxoplasmosishiv aids

Identifiers

PMID41993768
PMCPMC13081193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.